Clin2
NCT04930887Possibly a fitRecruiting

Numbing injection in the face to ease craniofacial pain

Craniofacial PainMigraineCluster HeadacheTrigeminal Autonomic CephalgiaSphenopalatine Ganglion NeuralgiaParoxysmal Hemicrania

Treatments studied

Part of Brain & nervous system, Mouth & dental, Pain clinical trials.

This trial tests whether an injection of a numbing medicine (bupivacaine) guided by an endoscope can reduce craniofacial pain. It may help people with certain headache or facial pain conditions by targeting the pain area more precisely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
15 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You have craniofacial pain (such as migraine, cluster headache, or facial nerve-related headache) and have seen the Stanford Pain or ENT clinic
  • You are between 18 and 80 years old
  • You are not allergic to bupivacaine (the numbing medicine used in the injection)
  • You are able and willing to take part in this study and attend required visits
  • You are able to give informed consent yourself (not decisionally impaired)
  • You are not pregnant and can follow study rules about pregnancy

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07764783Not yet recruiting· Phase 2
Numbing block for ongoing migraine and sinus pressure

This study tests a numbing medicine placed in the nose to relieve migraine pain and sinus pressure. It can help people who have frequent headaches with sensitivity to light, nausea, or trouble functioning.

Springfield, Massachusetts
NCT07402954Recruiting
Test of lidocaine infusion for severe migraine or face pain

This trial tests whether giving a numbing medicine (lidocaine) into a small artery in the face (the external carotid artery) can help people with hard-to-treat chronic migraines or persistent face/skull pain. It is for those who haven't found relief from standard treatments.

Galveston, Texas
NCT06621329Recruiting· Phase 2/Phase 3
Numbing shot for headache after brain bleed

This trial tests a numbing injection inside the nose to quickly relieve severe headaches caused by a brain bleed (subarachnoid hemorrhage). It may help reduce pain without strong medicines.

Sacramento, California
NCT07535411Not yet recruiting· Phase 4
Long-acting numbing medication for interventional radiology pain

This trial tests whether a special long-acting numbing medication (bupivacaine liposome) can better reduce pain during and after interventional radiology procedures. Interventional radiology uses imaging to guide minimally invasive treatments, and this medication may help you stay more comfortable during the procedure.

NCT03737292Recruiting· Phase 4
Numbing medicine for chest surgery pain after small lung operations

This trial tests whether a long-lasting numbing shot (liposomal bupivacaine) works better than a regular numbing shot (plain bupivacaine) for pain after minimally invasive chest surgery. It may help you have less post-surgery pain and potentially use less pain medication.

Hershey, Pennsylvania
NCT04575688Enrolling by invitation· Phase 4
Nerve-block injection options for ankle or heel surgery

This trial compares two methods of numbing pain—an injection near the joint versus a nerve block—during ankle or hindfoot surgery. It aims to see which approach helps with comfort and recovery after surgery.

Germantown, Tennessee

Hear when a new Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.